Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1aCondition 1b
10maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat63-D4Rat203)both12.6%pristane (150 ul) 69812pristane (150 ul)
10maximum body weight loss to initial body weight ratioDA/Ztmboth14.3%pristane (150 ul) 69811pristane (150 ul)
10maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat63-D4Rat203)both14.6%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69810type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10maximum body weight loss to initial body weight ratioDA/Ztmboth22.8%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69809type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat63-D4Rat203)both6.6%squalene (200 ul) 69808squalene (200 ul)
9maximum body weight loss to initial body weight ratioDA/Ztmboth12.8%squalene (200 ul) 69807squalene (200 ul)
24maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-Spr)both10.6%pristane (150 ul) 69806pristane (150 ul)
16maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-D4Rat84)both8.8%pristane (150 ul) 69805pristane (150 ul)
17maximum body weight loss to initial body weight ratioDA/Ztmboth14.1%pristane (150 ul) 69804pristane (150 ul)
13maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Mgh17-D4Rat56)male6.6%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69803type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
9maximum body weight loss to initial body weight ratioDA/Ztmmale7.5%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69802type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
11maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Mgh17-D4Rat56)both0.7%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69801type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-Spr)both12.5%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69800type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-D4Rat84)both2.8%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69799type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
12maximum body weight loss to initial body weight ratioDA/Ztmboth13.4%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69798type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-D4Rat84)both5.9%Freund's complete adjuvant (100 ul) 69797Freund's complete adjuvant (100 ul)
16maximum body weight loss to initial body weight ratioDA/Ztmboth3.2%Freund's complete adjuvant (100 ul) 69796Freund's complete adjuvant (100 ul)
11maximum body weight loss to initial body weight ratioDA.PVG.1AV1-(D4Rat155-D4Rat84)both9.6%squalene (200 ul) 69795squalene (200 ul)
15maximum body weight loss to initial body weight ratioDA/Ztmboth12.8%squalene (200 ul) 69794squalene (200 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both90%pristane (150 ul) 69725pristane (150 ul)
10percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%pristane (150 ul) 69724pristane (150 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69723type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69722type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat63-D4Rat203)both100%squalene (200 ul) 69721squalene (200 ul)
9percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%squalene (200 ul) 69720squalene (200 ul)
24percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-Spr)both100%pristane (150 ul) 69719pristane (150 ul)
16percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-D4Rat84)both69%pristane (150 ul) 69718pristane (150 ul)
18percentage of study population developing experimental arthritis during a period of timePVG.1AV1both33%pristane (150 ul) 69717pristane (150 ul)
17percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%pristane (150 ul) 69716pristane (150 ul)
13percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Mgh17-D4Rat56)male100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69715type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
9percentage of study population developing experimental arthritis during a period of timeDA/Ztmmale100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69714type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
11percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Mgh17-D4Rat56)both100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69713type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-Spr)both100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69712type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-D4Rat84)both71%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69711type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
15percentage of study population developing experimental arthritis during a period of timePVG.1AV1both33%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69710type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
12percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69709type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-D4Rat84)both36%Freund's complete adjuvant (100 ul) 69708Freund's complete adjuvant (100 ul)
15percentage of study population developing experimental arthritis during a period of timePVG.1AV1both0%Freund's complete adjuvant (100 ul) 69707Freund's complete adjuvant (100 ul)
16percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth88%Freund's complete adjuvant (100 ul) 69706Freund's complete adjuvant (100 ul)
11percentage of study population developing experimental arthritis during a period of timeDA.PVG.1AV1-(D4Rat155-D4Rat84)both73%squalene (200 ul) 69705squalene (200 ul)
10percentage of study population developing experimental arthritis during a period of timePVG.1AV1both0%squalene (200 ul) 69704squalene (200 ul)
15percentage of study population developing experimental arthritis during a period of timeDA/Ztmboth100%squalene (200 ul) 69703squalene (200 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both15.5dpristane (150 ul) 69793pristane (150 ul)
10post-insult time to onset of experimental arthritisDA/Ztmboth14.2dpristane (150 ul) 69792pristane (150 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both16.4dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69791type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10post-insult time to onset of experimental arthritisDA/Ztmboth14.2dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69790type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat63-D4Rat203)both16.9dsqualene (200 ul) 69789squalene (200 ul)
9post-insult time to onset of experimental arthritisDA/Ztmboth14dsqualene (200 ul) 69788squalene (200 ul)
24post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-Spr)both12.5dpristane (150 ul) 69787pristane (150 ul)
16post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-D4Rat84)both13.1dpristane (150 ul) 69786pristane (150 ul)
18post-insult time to onset of experimental arthritisPVG.1AV1both38dpristane (150 ul) 69785pristane (150 ul)
17post-insult time to onset of experimental arthritisDA/Ztmboth12.1dpristane (150 ul) 69784pristane (150 ul)
13post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Mgh17-D4Rat56)male15.5dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69783type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
11post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Mgh17-D4Rat56)both15.4dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69781type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-Spr)both14.3dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69780type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-D4Rat84)both17.6dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69779type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
15post-insult time to onset of experimental arthritisPVG.1AV1both14.6dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69778type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
12post-insult time to onset of experimental arthritisDA/Ztmboth14.5dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69777type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-D4Rat84)both13.6dFreund's complete adjuvant (100 ul) 69776Freund's complete adjuvant (100 ul)
16post-insult time to onset of experimental arthritisDA/Ztmboth14.9dFreund's complete adjuvant (100 ul) 69775Freund's complete adjuvant (100 ul)
11post-insult time to onset of experimental arthritisDA.PVG.1AV1-(D4Rat155-D4Rat84)both16dsqualene (200 ul) 69774squalene (200 ul)
15post-insult time to onset of experimental arthritisDA/Ztmboth13dsqualene (200 ul) 69773squalene (200 ul)
9post-insult time to onset of experimental arthritisDA/Ztmmale15.2dtype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69782type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat63-D4Rat203)both750mg/lpristane (150 ul) 69772pristane (150 ul)
10serum orosomucoid 1 levelDA/Ztmboth840mg/lpristane (150 ul) 69771pristane (150 ul)
10serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat63-D4Rat203)both660mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69770type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10serum orosomucoid 1 levelDA/Ztmboth600mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69769type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
10serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat63-D4Rat203)both480mg/lsqualene (200 ul) 69768squalene (200 ul)
9serum orosomucoid 1 levelDA/Ztmboth790mg/lsqualene (200 ul) 69767squalene (200 ul)
24serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-Spr)both1060mg/lpristane (150 ul) 69766pristane (150 ul)
16serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-D4Rat84)both750mg/lpristane (150 ul) 69765pristane (150 ul)
18serum orosomucoid 1 levelPVG.1AV1both340mg/lpristane (150 ul) 69764pristane (150 ul)
17serum orosomucoid 1 levelDA/Ztmboth840mg/lpristane (150 ul) 69763pristane (150 ul)
13serum orosomucoid 1 levelDA.PVG.1AV1-(D4Mgh17-D4Rat56)male540mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69762type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
9serum orosomucoid 1 levelDA/Ztmmale590mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69761type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
11serum orosomucoid 1 levelDA.PVG.1AV1-(D4Mgh17-D4Rat56)both540mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69760type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-Spr)both660mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69759type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-D4Rat84)both500mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69758type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
15serum orosomucoid 1 levelPVG.1AV1both250mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69757type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
12serum orosomucoid 1 levelDA/Ztmboth790mg/ltype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69756type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
14serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-D4Rat84)both370mg/lFreund's complete adjuvant (100 ul) 69755Freund's complete adjuvant (100 ul)
15serum orosomucoid 1 levelPVG.1AV1both340mg/lFreund's complete adjuvant (100 ul) 69754Freund's complete adjuvant (100 ul)
16serum orosomucoid 1 levelDA/Ztmboth540mg/lFreund's complete adjuvant (100 ul) 69753Freund's complete adjuvant (100 ul)
11serum orosomucoid 1 levelDA.PVG.1AV1-(D4Rat155-D4Rat84)both790mg/lsqualene (200 ul) 69752squalene (200 ul)
10serum orosomucoid 1 levelPVG.1AV1both150mg/lsqualene (200 ul) 69751squalene (200 ul)
15serum orosomucoid 1 levelDA/Ztmboth1060mg/lsqualene (200 ul) 69750squalene (200 ul)